PHARMACISTS' REPORT
 
FDA Approves First IV Treatment for Migraine Prevention
Eptinezumab-jjmr (Vyepti, Lundbeck) decreased mean monthly migraine days in adult patients in 2 phase 3 clinical trials.
Read more
 
 
Pharmacist Groups Support Supreme Court PBM Case
Several pharmacy groups said they will file a brief in the Supreme Court case, Rutledge v. the Pharmaceutical Care Management Association.
Read more
Read More
 
Top 5 Things to Know About COVID-19
Physicians On-board with Herpes Zoster Vaccine
Express Scripts Report: Top Drug Classes Driving Spending Growth
Harmons Pharmacies Are Special